1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Naloxegol
Trade Name:
Movantik
Manufacturer/Distributor:
AstraZeneca Canada
Classification:
Miscellaneous GI drug
ATC Class:
A06AH - peripheral opioid receptor antagonist
Status:
active
Notice of Compliance (yyyy/mm/dd):
2015/06/02
Date Marketed in Canada (yyyy/mm/dd):
2015/08/27
Presentation:
Tablet: 12.5 mg. DIN: 02442167
Tablet: 25 mg. DIN: 02442175
Comments:
Naloxegol is for the treatment of opioid-induced constipation in adult patients with non-cancer pain who have had an inadequate response to laxative(s).
Back to:
Drug Product Listings 
